GNI Group Ltd. (TSE: 2160, “GNI Group” or the “Company”) announces that it has completed the acquisition of all shares of Ayumi Pharmaceutical Holdings Co., Ltd. from shareholders led by Blackstone. As a result, Ayumi Pharmaceutical Holdings Co., Ltd. and its subsidiary, Ayumi Pharmaceutical Co., Ltd. (“Ayumi Pharmaceutical”), have become wholly owned subsidiaries of the Company. Since its founding in 2001 and listing in 2007, GNI Group has pursued global growth as a Japan-originated company, while expanding its business operations in China, the United States and Australia.
Read the full article: GNI Group Completes Acquisition of AYUMI Pharmaceutical from Blackstone //
Source: https://www.globenewswire.com/news-release/2026/07/02/3321062/0/en/gni-group-completes-acquisition-of-ayumi-pharmaceutical.html